Related Experiment Videos
[Which hypertensive patient requires diuretic therapy?]
1Abteilung für Nephrologie und Hypertonie, Universität Bern.
Therapeutische Umschau. Revue Therapeutique
|July 14, 2000
Summary
Diuretics, particularly low-dose thiazides, remain effective first-line treatments for hypertension, significantly reducing mortality and cardiovascular events. Their use should be reconsidered due to proven efficacy and safety, especially in combination therapies.
Area of Science:
- Cardiology
- Pharmacology
- Nephrology
Context:
- The use of diuretics as first-line hypertension treatment has declined despite established efficacy.
- Current trends overlook the benefits of these inexpensive antihypertensive drugs.
Purpose:
- To review the evidence supporting the use of diuretics, particularly low-dose thiazides, as first-line agents for hypertension.
- To encourage reconsideration of diuretic use in light of their documented benefits and safety profile.
Summary:
- 16 placebo-controlled studies involving over 13,000 patients show diuretics reduce total mortality (11%), cerebrovascular events (34%), and coronary morbidity (29%).
- Low-dose thiazides achieve comparable blood pressure reduction to high-dose versions without significant metabolic side effects.
- Diuretics are effective in combination therapy, counteracting compensatory mechanisms and further reducing cardiovascular mortality.
Impact:
- Low-dose diuretics are recommended for mild, uncomplicated essential hypertension and specific conditions like heart failure and renal failure.
- Evidence supports the primary preventive effects of low-dose thiazide diuretics against cardiovascular events.
- Re-evaluating diuretic use can optimize hypertension management, improve patient outcomes, and reduce healthcare costs.